LIPANTIL MICRO 140 Milligram Capsule
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
19-04-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
FENOFIBRATE
Available from:
Abbott Healthcare Products Ltd
INN (International Name):
FENOFIBRATE
Dosage:
140 Milligram
Pharmaceutical form:
Capsule
Prescription type:
Product subject to prescription which may be renewed (B)
Authorization status:
Withdrawn
Authorization date:
2010-02-15
Summary of Product characteristics
IRISH MEDICINES BOARD ACTS 1995 AND 2006
MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007
(S.I. NO.540 OF 2007)
PA0108/030/002
Case No: 2062250
The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to
SOLVAY HEALTHCARE LIMITED
MANSBRIDGE ROAD, WEST END, SOUTHAMPTON SO18 3JD, ENGLAND
an authorisation, subject to the provisions of the said Regulations, in respect of the product
LIPANTIL MICRO 140 MG CAPSULES, HARD
The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as
may be specified in the said Regulations as listed on the reverse of this document.
This authorisation, unless previously revoked, shall continue in force from 31/03/2009 until 15/11/2011.
Signed on behalf of the Irish Medicines Board this
________________
A person authorised in that behalf by the said Board.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 31/03/2009_
_CRN 2062250_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
4 CLINICAL PARTICULARS
5 PHARMACOLOGICAL PROPERTIES
6 PHARMACEUTICAL PARTICULARS
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 31/03/2009_
_CRN 2062250_
_page number: 2_
Read the complete document
